vs
Amphastar Pharmaceuticals, Inc.（AMPH）とPOWELL INDUSTRIES INC（POWL）の財務データ比較。上の社名をクリックして会社を切り替えられます
POWELL INDUSTRIES INCの直近四半期売上が大きい（$251.2M vs $183.1M、Amphastar Pharmaceuticals, Inc.の約1.4倍）。POWELL INDUSTRIES INCの純利益率が高く（16.5% vs 13.3%、差は3.1%）。POWELL INDUSTRIES INCの前年同期比売上増加率が高い（4.0% vs -1.8%）。POWELL INDUSTRIES INCの直近四半期フリーキャッシュフローが多い（$41.6M vs $24.6M）。過去8四半期でAmphastar Pharmaceuticals, Inc.の売上複合成長率が高い（3.2% vs -0.8%）
Amphastar Pharmaceuticalsは上場されている米国の特殊製薬企業です。2004年5月に設立され、主に吸入剤および鼻腔内投与製品の開発、生産、販売を行っており、特色ある医薬品分野で事業を展開しています。
Powell Industries, Inc.は1947年に設立され、テキサス州ヒューストンに本社を置く企業で、商業・産業分野向けに電力分配の監視・制御用の統合パッケージソリューション及び電気機器を製造・提供しています。
AMPH vs POWL — 直接比較
損益計算書 — Q4 FY2025 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $183.1M | $251.2M |
| 純利益 | $24.4M | $41.4M |
| 粗利率 | 46.8% | 28.4% |
| 営業利益率 | 19.4% | 17.0% |
| 純利益率 | 13.3% | 16.5% |
| 売上前年比 | -1.8% | 4.0% |
| 純利益前年比 | -35.7% | 19.1% |
| EPS（希薄化後） | $0.51 | $3.40 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $183.1M | $251.2M | ||
| Q3 25 | $191.8M | $298.0M | ||
| Q2 25 | $174.4M | $286.3M | ||
| Q1 25 | $170.5M | $278.6M | ||
| Q4 24 | $186.5M | $241.4M | ||
| Q3 24 | $191.2M | $275.1M | ||
| Q2 24 | $182.4M | $288.2M | ||
| Q1 24 | $171.8M | $255.1M |
| Q4 25 | $24.4M | $41.4M | ||
| Q3 25 | $17.4M | $51.4M | ||
| Q2 25 | $31.0M | $48.2M | ||
| Q1 25 | $25.3M | $46.3M | ||
| Q4 24 | $38.0M | $34.8M | ||
| Q3 24 | $40.4M | $46.1M | ||
| Q2 24 | $37.9M | $46.2M | ||
| Q1 24 | $43.2M | $33.5M |
| Q4 25 | 46.8% | 28.4% | ||
| Q3 25 | 51.4% | 31.4% | ||
| Q2 25 | 49.6% | 30.7% | ||
| Q1 25 | 50.0% | 29.9% | ||
| Q4 24 | 46.5% | 24.7% | ||
| Q3 24 | 53.3% | 29.2% | ||
| Q2 24 | 52.2% | 28.4% | ||
| Q1 24 | 52.4% | 24.6% |
| Q4 25 | 19.4% | 17.0% | ||
| Q3 25 | 13.2% | 21.2% | ||
| Q2 25 | 24.2% | 21.0% | ||
| Q1 25 | 21.9% | 21.1% | ||
| Q4 24 | 24.2% | 14.7% | ||
| Q3 24 | 29.8% | 20.4% | ||
| Q2 24 | 30.3% | 19.9% | ||
| Q1 24 | 27.9% | 15.5% |
| Q4 25 | 13.3% | 16.5% | ||
| Q3 25 | 9.0% | 17.3% | ||
| Q2 25 | 17.8% | 16.8% | ||
| Q1 25 | 14.8% | 16.6% | ||
| Q4 24 | 20.4% | 14.4% | ||
| Q3 24 | 21.1% | 16.7% | ||
| Q2 24 | 20.8% | 16.0% | ||
| Q1 24 | 25.1% | 13.1% |
| Q4 25 | $0.51 | $3.40 | ||
| Q3 25 | $0.37 | $4.23 | ||
| Q2 25 | $0.64 | $3.96 | ||
| Q1 25 | $0.51 | $3.81 | ||
| Q4 24 | $0.74 | $2.86 | ||
| Q3 24 | $0.78 | $3.77 | ||
| Q2 24 | $0.73 | $3.79 | ||
| Q1 24 | $0.81 | $2.75 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $282.8M | $500.8M |
| 総負債低いほど良い | $608.7M | — |
| 株主資本純資産 | $788.8M | $668.9M |
| 総資産 | $1.6B | $1.1B |
| 負債/資本比率低いほどレバレッジが低い | 0.77× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $282.8M | $500.8M | ||
| Q3 25 | $276.2M | $475.5M | ||
| Q2 25 | $231.8M | $433.0M | ||
| Q1 25 | $236.9M | $389.3M | ||
| Q4 24 | $221.6M | $373.4M | ||
| Q3 24 | $250.5M | $358.4M | ||
| Q2 24 | $217.8M | $374.0M | ||
| Q1 24 | $289.6M | $365.3M |
| Q4 25 | $608.7M | — | ||
| Q3 25 | $608.6M | — | ||
| Q2 25 | $607.7M | — | ||
| Q1 25 | $603.9M | — | ||
| Q4 24 | $601.6M | — | ||
| Q3 24 | $596.4M | — | ||
| Q2 24 | $586.9M | — | ||
| Q1 24 | $594.0M | — |
| Q4 25 | $788.8M | $668.9M | ||
| Q3 25 | $776.7M | $640.8M | ||
| Q2 25 | $757.5M | $594.9M | ||
| Q1 25 | $751.3M | $541.4M | ||
| Q4 24 | $732.3M | $496.3M | ||
| Q3 24 | $727.7M | $483.1M | ||
| Q2 24 | $713.3M | $436.7M | ||
| Q1 24 | $672.4M | $393.8M |
| Q4 25 | $1.6B | $1.1B | ||
| Q3 25 | $1.7B | $1.1B | ||
| Q2 25 | $1.6B | $1.0B | ||
| Q1 25 | $1.6B | $965.4M | ||
| Q4 24 | $1.6B | $912.7M | ||
| Q3 24 | $1.5B | $928.2M | ||
| Q2 24 | $1.5B | $869.0M | ||
| Q1 24 | $1.6B | $849.6M |
| Q4 25 | 0.77× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.80× | — | ||
| Q1 25 | 0.80× | — | ||
| Q4 24 | 0.82× | — | ||
| Q3 24 | 0.82× | — | ||
| Q2 24 | 0.82× | — | ||
| Q1 24 | 0.88× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $32.9M | $43.6M |
| フリーキャッシュフロー営業CF - 設備投資 | $24.6M | $41.6M |
| FCFマージンFCF / 売上 | 13.4% | 16.6% |
| 設備投資強度設備投資 / 売上 | 4.5% | 0.8% |
| キャッシュ転換率営業CF / 純利益 | 1.35× | 1.05× |
| 直近12ヶ月FCF直近4四半期 | $121.2M | $161.5M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $32.9M | $43.6M | ||
| Q3 25 | $52.6M | $61.1M | ||
| Q2 25 | $35.6M | $47.4M | ||
| Q1 25 | $35.1M | $22.4M | ||
| Q4 24 | $29.0M | $37.1M | ||
| Q3 24 | $60.0M | $-6.0M | ||
| Q2 24 | $69.1M | $13.8M | ||
| Q1 24 | $55.3M | $17.0M |
| Q4 25 | $24.6M | $41.6M | ||
| Q3 25 | $47.2M | $59.3M | ||
| Q2 25 | $25.0M | $42.3M | ||
| Q1 25 | $24.4M | $18.3M | ||
| Q4 24 | $16.6M | $34.9M | ||
| Q3 24 | $46.2M | $-14.4M | ||
| Q2 24 | $63.1M | $12.4M | ||
| Q1 24 | $46.5M | $16.1M |
| Q4 25 | 13.4% | 16.6% | ||
| Q3 25 | 24.6% | 19.9% | ||
| Q2 25 | 14.3% | 14.8% | ||
| Q1 25 | 14.3% | 6.6% | ||
| Q4 24 | 8.9% | 14.4% | ||
| Q3 24 | 24.1% | -5.3% | ||
| Q2 24 | 34.6% | 4.3% | ||
| Q1 24 | 27.1% | 6.3% |
| Q4 25 | 4.5% | 0.8% | ||
| Q3 25 | 2.8% | 0.6% | ||
| Q2 25 | 6.1% | 1.8% | ||
| Q1 25 | 6.3% | 1.5% | ||
| Q4 24 | 6.7% | 0.9% | ||
| Q3 24 | 7.2% | 3.1% | ||
| Q2 24 | 3.3% | 0.5% | ||
| Q1 24 | 5.1% | 0.4% |
| Q4 25 | 1.35× | 1.05× | ||
| Q3 25 | 3.03× | 1.19× | ||
| Q2 25 | 1.15× | 0.98× | ||
| Q1 25 | 1.39× | 0.48× | ||
| Q4 24 | 0.76× | 1.07× | ||
| Q3 24 | 1.48× | -0.13× | ||
| Q2 24 | 1.82× | 0.30× | ||
| Q1 24 | 1.28× | 0.51× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AMPH
| Other Products | $62.4M | 34% |
| Baqsimi | $46.7M | 26% |
| Primatenemist | $27.9M | 15% |
| Epinephrine | $17.1M | 9% |
| Lidocaine | $14.9M | 8% |
| Glucagon | $14.1M | 8% |
POWL
| Oil And Gas Service | $97.9M | 39% |
| Electricity | $69.3M | 28% |
| Commercial And Other Industrial | $40.6M | 16% |
| Petrochemical | $22.8M | 9% |
| Other Customers | $12.0M | 5% |
| Light Rail Traction Power Customer | $8.6M | 3% |
